NEW YORK (GenomeWeb News) – Response Genetics today said that it has received the third milestone payment from GlaxoSmithKline related to a licensing agreement reached by the two firms in March 2010.

Response Genetics received the milestone payment of $500,000 upon notice by the US Patent and Trademark Office that its patent titled "Methods, primers, Probes, and Kits Useful for the Detection of BRAF Mutations" has been allowed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: gene linked to expansion of the human neocortex, and more.

The National Institute of General Medical Sciences director says changes the agency made have allow it to boost success rates.

Ancient DNA indicates Stone Age, hunter-gather inhabitants of Britain imported wheat.

Joel Achenbach explores at National Geographic why people find science difficult to believe.